Overview

Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH

Status:
Completed
Trial end date:
2018-08-14
Target enrollment:
Participant gender:
Summary
Clinical Trial to Compare the Efficacy and Safety of Solifenacin/Tamsulosin Combination Therapy with Tamsulosin Monotherapy for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia
Phase:
Phase 3
Details
Lead Sponsor:
Jeil Pharmaceutical Co., Ltd.
Treatments:
Solifenacin Succinate
Tamsulosin